The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2

被引:25
作者
Baan, Bart [1 ]
van Dam, Hans [1 ]
van der Zon, Gerard C. M. [1 ]
Maassen, J. Antonie [1 ]
Ouwens, D. Margriet [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Sect Signal Transduct & Ageing, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1210/me.2005-0289
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The stimulation of cells with physiological concentrations of insulin induces a variety of responses, e. g. an increase in glucose uptake, induction of glycogen and protein synthesis, and gene expression. One of the determinants regulating insulin-mediated gene expression may be activating transcription factor 2 (ATF2). Insulin activates ATF2 by phosphorylation of Thr69 and Thr71 via a two-step mechanism, in which ATF2-Thr71 phosphorylation precedes the induction of ATF2-Thr69+71 phosphorylation by several minutes. We previously found that in c-Jun N-terminal kinase (JNK)-/- fibroblasts, cooperation of the ERK1/2 and p38 pathways is required for two-step ATF2-Thr69+71 phosphorylation in response to growth factors. Because JNK is also capable of phosphorylating ATF2, we assessed the involvement of JNK, ERK1/2 and p38 in the insulin-induced two-step ATF2 phosphorylation in JNK-expressing A14 fibroblasts and 3T3L1-adipocytes. The induction of ATF2-Thr71 phosphorylation was sensitive to MAPK kinase (MEK) 1/2-inhibition with U0126, and this phosphorylation coincided with nuclear translocation of phosphorylated ERK1/2. Use of the JNK inhibitor SP600125 or expression of dominant-negative JNK-activator SAPK kinase (SEK1) prevented the induction of ATF2-Thr69+71, but not ATF2-Thr71 phosphorylation by insulin. ATF2-dependent transcription was also sensitive to SP-treatment. Abrogation of p38 activation with SB203580 or expression of dominant-negative MKK6 had no inhibitory effect on these events. In agreement with this, the onset of ATF2-Thr69+71 phosphorylation coincided with the nuclear translocation of phosphorylated JNK. Finally, in vitro kinase assays using nuclear extracts indicated that ERK1/2 preceded JNK translocation. We conclude that sequential activation and nuclear appearance of ERK1/2 and JNK, rather than p38, underlies the two-step insulin-induced ATF2 phosphorylation in JNK-expressing cells.
引用
收藏
页码:1786 / 1795
页数:10
相关论文
共 32 条
[1]
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]
THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[3]
Activating transcription factor-2 is a positive regulator in CaM kinase IV - Induced human insulin gene expression [J].
Ban, N ;
Yamada, Y ;
Someya, Y ;
Ihara, Y ;
Adachi, T ;
Kubota, A ;
Watanabe, R ;
Kuroe, A ;
Inada, A ;
Miyawaki, K ;
Sunaga, Y ;
Shen, ZP ;
Iwakura, T ;
Tsukiyama, K ;
Toyokuni, S ;
Tsuda, K ;
Seino, Y .
DIABETES, 2000, 49 (07) :1142-1148
[4]
Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes [J].
Beier, F ;
Lee, RJ ;
Taylor, AC ;
Pestell, RG ;
LuValle, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1433-1438
[5]
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[6]
INSULIN STIMULATION OF GENE-EXPRESSION MEDIATED BY P21RAS ACTIVATION [J].
BURGERING, BMT ;
MEDEMA, RH ;
MAASSEN, JA ;
VANDEWETERING, ML ;
VANDEREB, AJ ;
MCCORMICK, F ;
BOS, JL .
EMBO JOURNAL, 1991, 10 (05) :1103-1109
[7]
p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene [J].
Cao, WH ;
Daniel, KW ;
Robidoux, J ;
Puigserver, P ;
Medvedev, AV ;
Bai, X ;
Floering, LM ;
Spiegelman, BM ;
Collins, S .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :3057-3067
[8]
SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[9]
Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[10]
A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase [J].
Fox, T ;
Coll, JT ;
Xie, XL ;
Ford, PJ ;
Germann, UA ;
Porter, MD ;
Pazhanisamy, S ;
Fleming, MA ;
Galullo, V ;
Su, MSS ;
Wilson, KP .
PROTEIN SCIENCE, 1998, 7 (11) :2249-2255